A Queen's University spin-out company that manufactures chips for detecting protein levels has won £500,000 in investment from a venture capital fund.
Causeway Sensors was founded by Dr Robert Pollard, Professor Robert Bowman and Dr John Nelson of Queen's, and has won funding from Kernel Capital.
Their company has developed nano-structured chips for detecting and measuring proteins.
The technology can be used for detecting cancer and other diseases in their early stages, and in food security and drug discovery.
It is to use Kernel's support to commercialise its technology, with a focus on medical diagnostics.
Jayne Brady, partner at Kernel Capital, said: "Causeway Sensors is a prime example of the success that can be achieved from bringing a concept through the research to commercialisation process.
"This investment will help Causeway to develop the potential of its nanotechnology and to grow and scale both nationally and internationally while also stimulating the local economy and creating new employment opportunities."